Utah Medical Products (NASDAQ:UTMD) Share Price Crosses Below Two Hundred Day Moving Average – Time to Sell?

Utah Medical Products, Inc. (NASDAQ:UTMD) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $58.26 and traded as low as $57.12. Utah Medical Products shares last traded at $57.39, with a volume of 10,823 shares.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (d+)” rating on shares of Utah Medical Products in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company has an average rating of “Sell”.

Utah Medical Products Stock Up 0.1%

The stock’s 50-day moving average price is $57.39 and its 200 day moving average price is $58.26. The firm has a market cap of $183.88 million, a price-to-earnings ratio of 16.21 and a beta of 0.33.

Utah Medical Products (NASDAQ:UTMD) last released its earnings results on Thursday, October 23rd. The medical instruments supplier reported $0.82 earnings per share for the quarter. The business had revenue of $9.81 million for the quarter. Utah Medical Products had a return on equity of 9.89% and a net margin of 30.08%.

Utah Medical Products Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, January 5th. Stockholders of record on Tuesday, December 16th will be given a dividend of $0.31 per share. This is a boost from Utah Medical Products’s previous quarterly dividend of $0.31. This represents a $1.24 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date is Tuesday, December 16th. Utah Medical Products’s dividend payout ratio (DPR) is presently 35.03%.

Institutional Investors Weigh In On Utah Medical Products

Institutional investors and hedge funds have recently bought and sold shares of the business. Nuveen LLC acquired a new position in shares of Utah Medical Products in the 1st quarter valued at $449,000. Jump Financial LLC bought a new stake in Utah Medical Products in the first quarter valued at about $370,000. Brandes Investment Partners LP raised its position in Utah Medical Products by 12.0% in the second quarter. Brandes Investment Partners LP now owns 271,322 shares of the medical instruments supplier’s stock worth $15,444,000 after purchasing an additional 29,073 shares in the last quarter. Hotchkis & Wiley Capital Management LLC lifted its stake in Utah Medical Products by 35.2% during the first quarter. Hotchkis & Wiley Capital Management LLC now owns 101,640 shares of the medical instruments supplier’s stock worth $5,696,000 after purchasing an additional 26,460 shares during the period. Finally, LSV Asset Management boosted its holdings in Utah Medical Products by 8.8% during the second quarter. LSV Asset Management now owns 12,974 shares of the medical instruments supplier’s stock valued at $738,000 after purchasing an additional 1,053 shares in the last quarter. Institutional investors own 69.60% of the company’s stock.

Utah Medical Products Company Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.